Boston Scientific Corp. posted revenue gains across its varied product categories, helped by strong performance in emerging markets.
Boston Scientific Corp. beat Wall Street’s second-quarter profit expectations but fell shy of analysts’ predictions on revenue. During an earnings call on 24 July, the company’s leadership detailed quarterly results and outlined expectations for the rest of the fiscal year.
CEO Michael Mahoney said he is “enthusiastic” about the
Medtech Insight sat down with Jared Bunch, chair of AF Center of Excellence Task Force, at HRS 2025 to discuss the newly HRS released framework for Afib Center of Excellence and get his perspective on the role industry could play to help clinicians improve patient outcomes.
Former FDA Commissioner Robert Califf urged the Heart Rhythm Society to engage actively amid federal funding cuts. He highlighted collaboration among researchers, advocates for healthcare integration, and the importance of addressing social determinants of health, while discussing lobbying strategies and the challenges faced by medtech companies.
The US FDA continues to issue early alerts as part of its communications pilot aimed at improving how the agency manages recalls. This time, the agency is notifying users about two separate intravascular catheters.
As it celebrates 75 years shaping the medtech industry, Medtronic invited Medtech Insight to its Minneapolis headquarters to get a closer look at the company’s past, what it’s working on now, and what’s on the horizon.
